| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |